FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2651201803> ?p ?o ?g. }

• W2651201803 endingPage "107" @default.
• W2651201803 startingPage "100" @default.
• W2651201803 abstract "Background and aims Oxidative modification of lipoproteins is a crucial step in atherosclerosis development. Isotopic-reinforced polyunsaturated fatty acids (D-PUFAs) are more resistant to reactive oxygen species-initiated chain reaction of lipid peroxidation than regular hydrogenated (H-)PUFAs. We aimed at investigating the effect of D-PUFA treatment on lipid peroxidation, hypercholesterolemia and atherosclerosis development. Methods Transgenic APOE*3-Leiden.CETP mice, a well-established model for human-like lipoprotein metabolism, were pre-treated with D-PUFAs or control H-PUFAs-containing diet (1.2%, w/w) for 4 weeks. Thereafter, mice were fed a Western-type diet (containing 0.15% cholesterol, w/w) for another 12 weeks, while continuing the D-/H-PUFA treatment. Results D-PUFA treatment markedly decreased hepatic and plasma F2-isoprostanes (approx. −80%) and prostaglandin F2α (approx. −40%) as compared to H-PUFA treatment. Moreover, D-PUFAs reduced body weight gain during the study (−54%) by decreasing body fat mass gain (−87%) without altering lean mass. D-PUFAs consistently reduced plasma total cholesterol levels (approx. −25%), as reflected in reduced plasma non-HDL-cholesterol (−28%). Additional analyses of hepatic cholesterol metabolism indicated that D-PUFAs reduced the hepatic cholesterol content (−21%). Sterol markers of intestinal cholesterol absorption and cholesterol breakdown were decreased. Markers of cholesterol synthesis were increased. Finally, D-PUFAs reduced atherosclerotic lesion area formation throughout the aortic root of the heart (−26%). Conclusions D-PUFAs reduce body weight gain, improve cholesterol handling and reduce atherosclerosis development by reducing lipid peroxidation and plasma cholesterol levels. D-PUFAs, therefore, represent a promising new strategy to broadly reduce rates of lipid peroxidation, and combat hypercholesterolemia and cardiovascular diseases." @default.
• W2651201803 created "2017-06-30" @default.
• W2651201803 creator A5022717354 @default.
• W2651201803 creator A5023531636 @default.
• W2651201803 creator A5025954248 @default.
• W2651201803 creator A5026894405 @default.
• W2651201803 creator A5035385427 @default.
• W2651201803 creator A5038170897 @default.
• W2651201803 creator A5050233317 @default.
• W2651201803 creator A5071412244 @default.
• W2651201803 creator A5081452014 @default.
• W2651201803 creator A5082153606 @default.
• W2651201803 date "2017-09-01" @default.
• W2651201803 modified "2023-09-27" @default.
• W2651201803 title "Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia" @default.
• W2651201803 cites W1749356921 @default.
• W2651201803 cites W1853891275 @default.
• W2651201803 cites W1865909644 @default.
• W2651201803 cites W1965969235 @default.
• W2651201803 cites W1968655223 @default.
• W2651201803 cites W1976616659 @default.
• W2651201803 cites W1990249966 @default.
• W2651201803 cites W1993002013 @default.
• W2651201803 cites W2000548860 @default.
• W2651201803 cites W2002817706 @default.
• W2651201803 cites W2014099400 @default.
• W2651201803 cites W2016346577 @default.
• W2651201803 cites W2022716681 @default.
• W2651201803 cites W2027544467 @default.
• W2651201803 cites W2031899050 @default.
• W2651201803 cites W2032149290 @default.
• W2651201803 cites W2044021620 @default.
• W2651201803 cites W2047629870 @default.
• W2651201803 cites W2070838021 @default.
• W2651201803 cites W2081950356 @default.
• W2651201803 cites W2084800681 @default.
• W2651201803 cites W2090552934 @default.
• W2651201803 cites W2092016388 @default.
• W2651201803 cites W2094229786 @default.
• W2651201803 cites W2107313543 @default.
• W2651201803 cites W2132328792 @default.
• W2651201803 cites W2137113092 @default.
• W2651201803 cites W2171269607 @default.
• W2651201803 cites W2171961487 @default.
• W2651201803 cites W2186765149 @default.
• W2651201803 cites W2211097714 @default.
• W2651201803 cites W2222677470 @default.
• W2651201803 cites W2234366308 @default.
• W2651201803 cites W2329306090 @default.
• W2651201803 cites W2461969811 @default.
• W2651201803 cites W2552951299 @default.
• W2651201803 cites W2562551269 @default.
• W2651201803 cites W2567820440 @default.
• W2651201803 cites W2590472357 @default.
• W2651201803 cites W51991299 @default.
• W2651201803 doi "https://doi.org/10.1016/j.atherosclerosis.2017.06.916" @default.
• W2651201803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28655430" @default.
• W2651201803 hasPublicationYear "2017" @default.
• W2651201803 type Work @default.
• W2651201803 sameAs 2651201803 @default.
• W2651201803 citedByCount "28" @default.
• W2651201803 countsByYear W26512018032017 @default.
• W2651201803 countsByYear W26512018032018 @default.
• W2651201803 countsByYear W26512018032019 @default.
• W2651201803 countsByYear W26512018032020 @default.
• W2651201803 countsByYear W26512018032021 @default.
• W2651201803 countsByYear W26512018032022 @default.
• W2651201803 countsByYear W26512018032023 @default.
• W2651201803 crossrefType "journal-article" @default.
• W2651201803 hasAuthorship W2651201803A5022717354 @default.
• W2651201803 hasAuthorship W2651201803A5023531636 @default.
• W2651201803 hasAuthorship W2651201803A5025954248 @default.
• W2651201803 hasAuthorship W2651201803A5026894405 @default.
• W2651201803 hasAuthorship W2651201803A5035385427 @default.
• W2651201803 hasAuthorship W2651201803A5038170897 @default.
• W2651201803 hasAuthorship W2651201803A5050233317 @default.
• W2651201803 hasAuthorship W2651201803A5071412244 @default.
• W2651201803 hasAuthorship W2651201803A5081452014 @default.
• W2651201803 hasAuthorship W2651201803A5082153606 @default.
• W2651201803 hasBestOaLocation W26512018032 @default.
• W2651201803 hasConcept C126322002 @default.
• W2651201803 hasConcept C134018914 @default.
• W2651201803 hasConcept C185592680 @default.
• W2651201803 hasConcept C19038510 @default.
• W2651201803 hasConcept C2776151105 @default.
• W2651201803 hasConcept C2778163477 @default.
• W2651201803 hasConcept C2780829032 @default.
• W2651201803 hasConcept C543025807 @default.
• W2651201803 hasConcept C55493867 @default.
• W2651201803 hasConcept C71924100 @default.
• W2651201803 hasConcept C86803240 @default.
• W2651201803 hasConceptScore W2651201803C126322002 @default.
• W2651201803 hasConceptScore W2651201803C134018914 @default.
• W2651201803 hasConceptScore W2651201803C185592680 @default.
• W2651201803 hasConceptScore W2651201803C19038510 @default.
• W2651201803 hasConceptScore W2651201803C2776151105 @default.
• W2651201803 hasConceptScore W2651201803C2778163477 @default.
• W2651201803 hasConceptScore W2651201803C2780829032 @default.

• next